Funding underway for groundbreaking cancer research - CKPGToday.ca

By Cheryl Jahn

Nov 10, 2023 | 9:30 AM

PRINCE GEORGE – The BC Cancer Foundation has launched a $2.2 million fundraising campaign to support a new, cutting-edge international precision radiation clinical trial, which will be led by Dr. Rob Olson and his team at BC Cancer Agency – Prince George Centre for the North. The new clinical trial, called SIMPLIFY, will be available at all six BC Cancer centres and at least 15 international sites.

The trial will help shape the future of precision radiation therapy internationally and further demonstrate BC Cancer’s global leadership in cancer research and innovation. SIMPLIFY will test the use of a single dose of Stereotactic ablative radiotherapy, a high-precision therapy that safely delivers higher doses of radiation to the tumour site, while limiting doses to healthy tissues, and is expected to reduce side effects and increase the chance of a complete remission for people with metastatic cancer.

Findings from Dr. Olson’s previous SABR trial, SABR-5, were published last fall with positive results. The trial used up to eight SABR treatments and found side effects from SABR are low and the control of cancer spread is high, as high as 90% at one year. Importantly, it found SABR treatments led to complete remission for some metastatic patients, where existing therapies are only effective at slowing or reducing the tumours.

“SABR destroys cancer cells and cancer DNA at the molecular level,” explains Dr. Olson.

Adblock test (Why?)

Funding underway for groundbreaking cancer research - CKPGToday.ca
Read More